MISMATCH REPAIR DEFICIENCY

Clinical trials for MISMATCH REPAIR DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new MISMATCH REPAIR DEFICIENCY trials appear

Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 1

New hope for patients whose cancer stopped responding to standard immunotherapy

Disease control Ongoing

This study is testing a new combination of immune-boosting drugs for people with advanced cancers whose disease has progressed after treatment with standard immunotherapies like pembrolizumab or nivolumab. It aims to see if adding a drug called NAI to other treatments can help sh…

Matched conditions: MISMATCH REPAIR DEFICIENCY

Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

MISMATCH REPAIR DEFICIENCY

Get alerted when new MISMATCH REPAIR DEFICIENCY trials appear

New hope for patients whose cancer stopped responding to standard immunotherapy